How inhaler use affects oral health in COPD patients
Part of Lungs & breathing clinical trials.
This study looks at how using a metered dose inhaler (a common type of inhaler) might impact your mouth and teeth if you have COPD. It aims to help understand and improve oral care for people using these inhalers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD for at least 6 months.
- You are 18 years or older.
- You use a metered dose inhaler as part of your treatment.
- You have no current COPD flare-up or respiratory infection.
- You are able to communicate and give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with COPD or asthma use their inhalers. It aims to understand common problems and find ways to improve treatment adherence.
This study checks how well COPD patients use their daily inhalers and finds ways to improve their technique. It aims to help you get the full benefit of your medication.
This study tests a program to help people with COPD manage their medications better. You may be able to join if you have COPD, use an inhaler, and have trouble with breathing or taking your medicine as prescribed.
This study looks at whether memory and thinking skills affect how well people with COPD use their inhalers. It may help find ways to improve inhaler technique and make treatment more effective.
This study tests whether providing inhaler training and phone reminders helps older adults use their medication correctly. You may be eligible if you are 65+, use a metered-dose inhaler, and are being treated for a lung condition.
This study tests how well a digital device that tracks your inhaler use works for people with lung conditions like COPD or asthma. It's a small initial study to see if this approach is helpful.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.